Neuron Specific Enolase in Ventricular Assist Device Recipients

NCT01643551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2014-12-18

No results posted yet for this study

Summary

An observational study of neuron specific enolase, as a marker of reperfusion injury, in LVAD recipients before and following VAD implantation.

Conditions

  • Advanced Heart Failure
  • Left Ventrucular Assist Device

Sponsors & Collaborators

Principal Investigators

  • Peter M Eckman, MD · University of Minnesota

  • Demitri Yannopoulos, MD · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-01-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01643551 on ClinicalTrials.gov